Ocuphire Pharma Inc expected to post a loss of 12 cents a share - Earnings Preview

Opus Genetics

10/05/2024 15:46

* Ocuphire Pharma Inc  OCUP.OQ   OCUP.O  is expected to show
a
rise in quarterly revenue when it reports  results on May 13
(estimated) for the period ending June 30 2024
    * The Farmington Hills Michigan-based  company is expected
to
report a 25.4% increase in revenue to $4.606 million from $3.67
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Ocuphire Pharma Inc is
for a
loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 34.0%
in the last three months. ​
    * Wall Street's median 12-month price target for Ocuphire
Pharma
Inc is $20.00​, above​ its last closing price of $1.96. ​​​

This summary was machine generated May 10 at 14:46 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)